Q3 2025 Management View CEO Herriot Tabuteau stated that "Axsome continues to lead in CNS innovation, driven by disciplined ...
This represents Alector's second failed neurodegenerative asset in a year, after an AbbVie-partnered asset missed in Alzheimer's last November. On latozinemab for frontotemporal dementia, Alector was ...
Alzheimer's disease is notorious for scrambling patients' daily rhythms. Restless nights with little sleep and increased ...
November is Alzheimer’s Awareness Month, a time to spotlight the growing impact of the disease across the United States and ...
While half of those genes are activated according to the body’s circadian rhythm, showing a clear connection to sleep, YKL-40 ...
The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...
9don MSN
40Hz sensory stimulation may benefit some Alzheimer's patients for years, small study suggests
A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...
(InvestigateTV) — When someone with dementia becomes lost or confused about their location, law enforcement officers often play a crucial role in finding them safely. However, when 61-year-old George ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback